CENTRAL TRUST Co cut its position in shares of Aetna Inc (NYSE:AET) by 5.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 17,196 shares of the company’s stock after selling 1,033 shares during the period. CENTRAL TRUST Co’s holdings in Aetna were worth $2,193,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in AET. FTB Advisors Inc. increased its position in shares of Aetna by 0.7% in the third quarter. FTB Advisors Inc. now owns 880 shares of the company’s stock valued at $101,000 after buying an additional 6 shares during the last quarter. Simmons Bank increased its position in shares of Aetna by 0.8% in the third quarter. Simmons Bank now owns 1,920 shares of the company’s stock valued at $221,000 after buying an additional 15 shares during the last quarter. National Asset Management Inc. increased its stake in Aetna by 0.8% in the third quarter. National Asset Management Inc. now owns 2,550 shares of the company’s stock worth $296,000 after buying an additional 20 shares in the last quarter. YHB Investment Advisors Inc. increased its stake in Aetna by 1.1% in the third quarter. YHB Investment Advisors Inc. now owns 2,225 shares of the company’s stock worth $257,000 after buying an additional 25 shares in the last quarter. Finally, Logan Capital Management Inc. increased its stake in Aetna by 0.6% in the third quarter. Logan Capital Management Inc. now owns 5,736 shares of the company’s stock worth $662,000 after buying an additional 37 shares in the last quarter. Institutional investors and hedge funds own 88.40% of the company’s stock.
Shares of Aetna Inc (NYSE:AET) traded down 1.027% during trading on Friday, hitting $130.575. 818,441 shares of the company traded hands. Aetna Inc has a 52 week low of $104.59 and a 52 week high of $136.50. The company has a market capitalization of $45.92 billion, a price-to-earnings ratio of 20.371 and a beta of 0.61. The company has a 50 day moving average price of $129.58 and a 200 day moving average price of $123.22.
Aetna (NYSE:AET) last issued its quarterly earnings data on Tuesday, January 31st. The company reported $1.63 EPS for the quarter, topping the Zacks’ consensus estimate of $1.44 by $0.19. The firm earned $15.73 billion during the quarter, compared to the consensus estimate of $15.84 billion. Aetna had a return on equity of 16.39% and a net margin of 3.58%. The firm’s revenue was up 4.4% on a year-over-year basis. During the same period in the prior year, the business earned $1.37 EPS. On average, analysts expect that Aetna Inc will post $8.87 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 28th. Investors of record on Thursday, April 13th will be paid a dividend of $0.50 per share. This is an increase from Aetna’s previous quarterly dividend of $0.25. This represents a $2.00 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date of this dividend is Tuesday, April 11th. Aetna’s dividend payout ratio is presently 15.67%.
A number of research firms have recently issued reports on AET. Jefferies Group LLC reaffirmed a “hold” rating and set a $133.00 price objective on shares of Aetna in a report on Thursday, April 13th. Zacks Investment Research raised shares of Aetna from a “hold” rating to a “buy” rating and set a $143.00 price objective for the company in a report on Tuesday, April 4th. Deutsche Bank AG began coverage on shares of Aetna in a report on Wednesday, April 5th. They set a “hold” rating and a $135.00 price objective for the company. CIBC reaffirmed an “outperform” rating on shares of Aetna in a report on Monday, April 3rd. Finally, Oppenheimer Holdings Inc. reaffirmed an “outperform” rating on shares of Aetna in a report on Friday, March 31st. Eight analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. Aetna presently has a consensus rating of “Buy” and an average target price of $136.65.
In related news, VP Francis S. Soistman, Jr. sold 6,607 shares of the company’s stock in a transaction on Wednesday, March 8th. The stock was sold at an average price of $131.98, for a total transaction of $871,991.86. Following the completion of the transaction, the vice president now directly owns 23,454 shares in the company, valued at approximately $3,095,458.92. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, insider Shawn M. Guertin sold 29,602 shares of the company’s stock in a transaction on Thursday, March 23rd. The stock was sold at an average price of $129.35, for a total value of $3,829,018.70. Following the transaction, the insider now owns 44,880 shares of the company’s stock, valued at $5,805,228. The disclosure for this sale can be found here. 0.90% of the stock is owned by corporate insiders.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc and related companies with MarketBeat.com's FREE daily email newsletter.